Company / Current Liabilities per Share
NovoCure Ltd Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$2.06
FY2025
5-year range
$1.39 / $7.06
FY2021-FY2025
Trend
-70.9%
vs FY2024
Sector context
#122 of 163
Health Care
What the data says
NovoCure Ltd's current liabilities per share of $2.06 is lower than 75% of companies in the Health Care sector (FY2025). Increased from $1.71 to $2.06 over the past 2 years.
Based on SEC 10-K filings.
2.06 in FY2025 with a 5-year CAGR of +12.5%.
Increased from $1.71 to $2.06 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +10.4%
- 5-Year CAGR
- +12.5%
- 10-Year CAGR
- -
Sector benchmark
Top 25% in Health CareTop 25% of 163This company $2.06 Sector average $28.65
▼
-92.8% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 70.9% year-over-year.
- Ranks #122 out of 163 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2024.
- Lowest current liabilities per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.06 | -70.9% |
| FY2024 | $7.06 | +314.3% |
| FY2023 | $1.71 | +11.7% |
| FY2022 | $1.53 | +9.6% |
| FY2021 | $1.39 | +22.1% |
| FY2020 | $1.14 | +23.3% |
| FY2019 | $0.93 | +28.3% |
| FY2018 | $0.72 | +25.1% |
| FY2017 | $0.58 | +31.0% |
| FY2016 | $0.44 | -79.3% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026